Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

Application of Clinical Genetics is a premier open-access journal published by Dove Medical Press Ltd., dedicated to advancing the field of clinical genetics since its inception in 2008. Based in New Zealand, this journal has established itself as a significant resource for researchers, clinicians, and students alike, contributing to the body of knowledge in both genetic medicine and clinical applications. With an impact factor reflecting its contributions to the field, the journal holds positions in the Q2 and Q3 quartiles of the 2023 Genetics categories, showcasing its relevance and scientific merit. Furthermore, it ranks #43 out of 99 in Clinical Genetics and #153 out of 347 in Biochemistry, Genetics, and Molecular Biology, indicating robust performance amongst its peers. The journal’s broad scope, encompassing various aspects of clinical genetics, ensures that it remains at the forefront of critical discussions, innovative research, and applications essential for the progression of personalized medicine. Researchers and professionals are encouraged to explore its openly accessible content that fosters collaboration and the sharing of knowledge in this dynamic and rapidly evolving field.

OPHTHALMIC GENETICS is a distinguished journal published by TAYLOR & FRANCIS INC, specializing in the intersection of genetics and ophthalmology. Established in 1981, the journal has become a vital resource for researchers, clinicians, and students interested in the genetic aspects of eye diseases and disorders. Despite not being an Open Access journal, it maintains a commendable impact within the academic community, as reflected by its Q3 ranking in clinical genetics and Q2 rankings in both ophthalmology and pediatrics in 2023. With a robust focus on clinical applications, OPHTHALMIC GENETICS aims to provide a platform for innovative research and insights that drive advancements in patient care and understanding of genetic conditions affecting vision. The journal's international readership is supported by its timely publication of articles that bridge the gap between genetic research and practical ophthalmological applications.

Case Reports in Neurology is a distinguished open-access journal published by KARGER, dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2009, the journal has provided a vital platform for the dissemination of clinical case reports, enhancing the understanding of various neurological disorders and their management. With an ISSN of 1662-680X, it is indexed in Scopus, ranking #295 out of 400 in the neurology (clinical) category for 2023, placing it in the 26th percentile. The journal welcomes contributions from researchers, clinicians, and students alike, offering insights into unique cases and treatment outcomes that can significantly impact clinical practice. Located in Basel, Switzerland, the journal emphasizes the importance of sharing exceptional clinical experiences that can inform future research and evidence-based practices. By promoting open access, Case Reports in Neurology ensures that valuable information is available to the global medical community, further bridging gaps in neurology research and clinical application.

Molecular Syndromology is a premier journal focused on the intricate connections between molecular genetics and syndromology, fostering discussions that advance our understanding of genetic disorders and their clinical implications. Published by KARGER, a distinguished name in medical and scientific publishing, this journal serves as a valuable platform for researchers, clinicians, and students in the field of genetics. With its ISSN 1661-8769 and E-ISSN 1661-8777, the journal has gained recognition in its category, currently positioned in the Q4 quartile for both genetic and clinical genetics disciplines according to the latest metrics. Despite being indexed lower in Scopus rankings, it addresses crucial gaps in research and offers open access options that enhance visibility and dissemination of knowledge. As it continues to converge from 2010 to 2024, Molecular Syndromology aims to bridge the gap between molecular research and its clinical applications, making a significant impact in the evolving landscape of genetic medicine.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS is a premier peer-reviewed journal published by Wiley, focusing on the intricate and evolving field of medical genetics. With its ISSN 1552-4868 and E-ISSN 1552-4876, the journal has established itself as a significant resource for researchers, professionals, and students alike, addressing cutting-edge developments in genetic research and clinical practice. Ranked in the top quartile (Q2) in both Genetics and clinical Genetics categories for 2023, it maintains an impressive Scopus ranking, positioning it within the 75th and 71st percentiles for Medicine and Genetics respectively. The journal encourages open access to its content, promoting wider dissemination of knowledge and fostering collaboration among medical genetics experts. From its inaugural issues in 1980 to its ongoing publications, the journal aims to bridge the gap between genetics research and its clinical applications, providing insights that reflect the latest advancements in the field. As it continues to serve the global medical community, the AMERICAN JOURNAL OF MEDICAL GENETICS PART C remains a vital source for those seeking to understand the complexities of genetic disorders and their implications for health and disease.

Modern Rheumatology Case Reports, published by Oxford University Press, is an essential platform dedicated to the dissemination of unique clinical cases within the field of rheumatology. Launched in 2017, this journal provides a valuable resource for researchers, clinicians, and students interested in the nuances of rheumatological conditions and their management. With an E-ISSN of 2472-5625, the journal is accessible to a global audience, fostering knowledge exchange and collaborative research. Although currently ranked in the Q4 quartile and positioned 53rd out of 73 in the Scopus Medicine Rheumatology category, the journal is committed to enhancing its impact in the discipline by focusing on innovative case reports that inform clinical practice and contribute to the evolving understanding of rheumatic diseases. This endeavor not only supports the academic community but also aims to inspire new avenues for research and diagnostics. As such, Modern Rheumatology Case Reports is poised to become a significant reference point for those dedicated to advancing rheumatological care.

Journal of Pediatric Genetics, published by GEORG THIEME VERLAG KG, is an essential resource in the field of pediatric medicine and genetics. With a focus on the genetic determinants of health and disease in children, this journal aims to advance the knowledge and application of genetic research in pediatric care. Although it has faced challenges in its indexing in recent years, it provides an important platform for practitioners and researchers dedicated to understanding the complexities of pediatric genetics. As evidenced by its position in Scopus ranks—ranked #209 in Pediatrics and #87 in Clinical Genetics—the journal serves a niche yet critical audience seeking to explore the interplay between genetic factors and childhood health outcomes. The Journal of Pediatric Genetics invites scholars and professionals to delve into its rich content, contributing to the ongoing discourse in this vital field, while the absence of open access highlights the journal’s curation of high-quality, peer-reviewed articles that are valued across academia and clinical practices.

Pediatric Neurology, a prestigious journal published by Elsevier Science Inc, is a leading resource in the field of child neurology and developmental neurosciences. With an impressive impact factor and categorization in the Q1 and Q2 quartiles across several relevant fields, including Pediatrics, Neurology, and Developmental Neuroscience, this journal is essential for researchers and healthcare professionals focused on pediatric neurological disorders. Since its inception in 1985, it has provided a platform for high-quality research, clinical studies, and reviews that drive advancements in diagnosis, treatment, and understanding of neurological conditions in children. Although the journal does not currently offer open access, it maintains a robust reputation in the academic community, bolstered by its prominent ranking in Scopus metrics. By engaging with the latest findings published in Pediatric Neurology, readers will gain vital insights that contribute to improving pediatric healthcare outcomes in neurology and neuroscience.

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.